Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages. 2003

Erwei Song, and Sang-Kyung Lee, and Derek M Dykxhoorn, and Carl Novina, and Dong Zhang, and Keith Crawford, and Jan Cerny, and Phillip A Sharp, and Judy Lieberman, and N Manjunath, and Premlata Shankar
Center for Blood Research, Harvard Medical School, Boston, Massachusetts 02115, USA.

Small interfering RNAs (siRNAs) can induce potent gene silencing by degradation of cognate mRNA. However, in dividing cells, the silencing lasts only 3 to 7 days, presumably because of siRNA dilution with cell division. Here, we investigated if sustained siRNA-mediated silencing of human immunodeficiency virus type 1 (HIV-1) is possible in terminally differentiated macrophages, which constitute an important reservoir of HIV in vivo. CCR5, the major HIV-1 coreceptor in macrophages, and the viral structural gene for p24 were targeted either singly or in combination. When transfected 2 days prior to infection, both CCR5 and p24 siRNAs effectively reduced HIV-1 infection for the entire 15-day period of observation, and combined targeting of both genes abolished infection. To investigate whether exogenously introduced siRNA is maintained stably in macrophages, we tested the kinetics of siRNA-mediated viral inhibition by initiating infections at various times (2 to 15 days) after transfection with CCR5 and p24 siRNAs. HIV suppression mediated by viral p24 siRNA progressively decreased and was lost by day 7 posttransfection. In contrast, viral inhibition by cellular CCR5 knockdown was sustained even when transfection preceded infection by 15 days, suggesting that the continued presence of target RNA may be needed for persistence of siRNA. The longer sustenance of CCR5 relative to p24 siRNA in uninfected macrophages was also confirmed by detection of internalized siRNA by modified Northern blot analysis. We also tested the potential of p24 siRNA to stably silence HIV in the setting of an established infection where the viral target gene is actively transcribed. Under these circumstances, long-term suppression of HIV replication could be achieved with p24 siRNA. Thus, siRNAs can induce potent and long-lasting HIV inhibition in nondividing cells such as macrophages.

UI MeSH Term Description Entries
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D016655 HIV Core Protein p24 A major core protein of the human immunodeficiency virus encoded by the HIV gag gene. HIV-seropositive individuals mount a significant immune response to p24 and thus detection of antibodies to p24 is one basis for determining HIV infection by ELISA and Western blot assays. The protein is also being investigated as a potential HIV immunogen in vaccines. HIV Major Core Protein p24,HIV gag Gene Product p24,HIV p24 Antigen,gag Protein p24, HIV,p24(HIV),HIV Protein p24,HTLV-III p24,p24 protein, Human Immunodeficiency Virus,HTLV III p24,p24 Antigen, HIV,p24, HIV Protein,p24, HTLV-III
D017931 DNA Primers Short sequences (generally about 10 base pairs) of DNA that are complementary to sequences of messenger RNA and allow reverse transcriptases to start copying the adjacent sequences of mRNA. Primers are used extensively in genetic and molecular biology techniques. DNA Primer,Oligodeoxyribonucleotide Primer,Oligodeoxyribonucleotide Primers,Oligonucleotide Primer,Oligonucleotide Primers,Primer, DNA,Primer, Oligodeoxyribonucleotide,Primer, Oligonucleotide,Primers, DNA,Primers, Oligodeoxyribonucleotide,Primers, Oligonucleotide
D019713 Receptors, CCR5 CCR receptors with specificity for CHEMOKINE CCL3; CHEMOKINE CCL4; and CHEMOKINE CCL5. They are expressed at high levels in T-LYMPHOCYTES; B-LYMPHOCYTES; MACROPHAGES; MAST CELLS; and NK CELLS. The CCR5 receptor is used by the HUMAN IMMUNODEFICIENCY VIRUS to infect cells. Antigens, CD195,CC Chemokine Receptor 5,CCR5 Receptors,CD195 Antigens,CC-CKR5,CCR5 Receptor,CKR5 Receptors,Receptors, CKR5,Receptor, CCR5
D020868 Gene Silencing Interruption or suppression of the expression of a gene at transcriptional or translational levels. Gene Inactivation,Inactivation, Gene,Silencing, Gene

Related Publications

Erwei Song, and Sang-Kyung Lee, and Derek M Dykxhoorn, and Carl Novina, and Dong Zhang, and Keith Crawford, and Jan Cerny, and Phillip A Sharp, and Judy Lieberman, and N Manjunath, and Premlata Shankar
March 2008, Journal of virology,
Erwei Song, and Sang-Kyung Lee, and Derek M Dykxhoorn, and Carl Novina, and Dong Zhang, and Keith Crawford, and Jan Cerny, and Phillip A Sharp, and Judy Lieberman, and N Manjunath, and Premlata Shankar
March 2004, Journal of virology,
Erwei Song, and Sang-Kyung Lee, and Derek M Dykxhoorn, and Carl Novina, and Dong Zhang, and Keith Crawford, and Jan Cerny, and Phillip A Sharp, and Judy Lieberman, and N Manjunath, and Premlata Shankar
January 2008, Clinical and experimental dermatology,
Erwei Song, and Sang-Kyung Lee, and Derek M Dykxhoorn, and Carl Novina, and Dong Zhang, and Keith Crawford, and Jan Cerny, and Phillip A Sharp, and Judy Lieberman, and N Manjunath, and Premlata Shankar
November 2003, Journal of virology,
Erwei Song, and Sang-Kyung Lee, and Derek M Dykxhoorn, and Carl Novina, and Dong Zhang, and Keith Crawford, and Jan Cerny, and Phillip A Sharp, and Judy Lieberman, and N Manjunath, and Premlata Shankar
April 2003, Journal of virology,
Erwei Song, and Sang-Kyung Lee, and Derek M Dykxhoorn, and Carl Novina, and Dong Zhang, and Keith Crawford, and Jan Cerny, and Phillip A Sharp, and Judy Lieberman, and N Manjunath, and Premlata Shankar
October 2014, Journal of investigative medicine : the official publication of the American Federation for Clinical Research,
Erwei Song, and Sang-Kyung Lee, and Derek M Dykxhoorn, and Carl Novina, and Dong Zhang, and Keith Crawford, and Jan Cerny, and Phillip A Sharp, and Judy Lieberman, and N Manjunath, and Premlata Shankar
September 2018, Scientific reports,
Erwei Song, and Sang-Kyung Lee, and Derek M Dykxhoorn, and Carl Novina, and Dong Zhang, and Keith Crawford, and Jan Cerny, and Phillip A Sharp, and Judy Lieberman, and N Manjunath, and Premlata Shankar
November 2001, Journal of virology,
Erwei Song, and Sang-Kyung Lee, and Derek M Dykxhoorn, and Carl Novina, and Dong Zhang, and Keith Crawford, and Jan Cerny, and Phillip A Sharp, and Judy Lieberman, and N Manjunath, and Premlata Shankar
November 2002, Journal of immunology (Baltimore, Md. : 1950),
Erwei Song, and Sang-Kyung Lee, and Derek M Dykxhoorn, and Carl Novina, and Dong Zhang, and Keith Crawford, and Jan Cerny, and Phillip A Sharp, and Judy Lieberman, and N Manjunath, and Premlata Shankar
July 2000, The Journal of infectious diseases,
Copied contents to your clipboard!